BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26864651)

  • 1. Inhibition of Growth and Metastasis of Colon Cancer by Delivering 5-Fluorouracil-loaded Pluronic P85 Copolymer Micelles.
    Zhu P; Zhao N; Sheng D; Hou J; Hao C; Yang X; Zhu B; Zhang S; Han Z; Wei L; Zhang L
    Sci Rep; 2016 Feb; 6():20896. PubMed ID: 26864651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.
    Zhang SS; Han ZP; Jing YY; Tao SF; Li TJ; Wang H; Wang Y; Li R; Yang Y; Zhao X; Xu XD; Yu ED; Rui YC; Liu HJ; Zhang L; Wei LX
    BMC Med; 2012 Aug; 10():85. PubMed ID: 22871210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a subpopulation of long-term tumor-initiating cells in colon cancer.
    Peng L; Xiong Y; Wang R; Xiang L; Zhou H; Gu H
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
    Ahn JY; Lee JS; Min HY; Lee HY
    Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotype.
    Paschall AV; Yang D; Lu C; Redd PS; Choi JH; Heaton CM; Lee JR; Nayak-Kapoor A; Liu K
    Oncotarget; 2016 Nov; 7(48):78698-78712. PubMed ID: 27659530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Breast Cancer Metastasis by Pluronic Copolymers with Moderate Hydrophilic-Lipophilic Balance.
    Sun H; Meng Q; Tang S; Su J; Yin Q; Chen L; Gu W; Yu H; Zhang Z; Wang S; Li Y
    Mol Pharm; 2015 Sep; 12(9):3323-31. PubMed ID: 26220770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
    Cutler MJ; Lowthers EL; Richard CL; Hajducek DM; Spagnuolo PA; Blay J
    BMC Cancer; 2015 Nov; 15():882. PubMed ID: 26552750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment with selective cyclooxygenase-2 inhibitor and fluorinated pyrimidines for liver metastasis of colon cancer.
    Matsunaga N; Yamada N; Ohira M; Tachimori A; Nishiguchi Y; Nishino H; Seki S; Hirakawa K
    Oncol Rep; 2004 Jan; 11(1):167-71. PubMed ID: 14654921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133
    Hemati H; Kaur J; Sobti RC; Trehanpati N
    Biochem Biophys Res Commun; 2020 May; 525(4):941-947. PubMed ID: 32173531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.
    Ma L; Qiao H; He C; Yang Q; Cheung CH; Kanwar JR; Sun X
    Invest New Drugs; 2012 Apr; 30(2):508-17. PubMed ID: 21080209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles.
    Russo A; Maiolino S; Pagliara V; Ungaro F; Tatangelo F; Leone A; Scalia G; Budillon A; Quaglia F; Russo G
    Oncotarget; 2016 Nov; 7(48):79670-79687. PubMed ID: 27835895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regorafenib as a potential adjuvant chemotherapy agent in disseminated small colon cancer: Drug selection outcome of a novel screening system using nanoimprinting 3-dimensional culture with HCT116-RFP cells.
    Yoshii Y; Furukawa T; Aoyama H; Adachi N; Zhang MR; Wakizaka H; Fujibayashi Y; Saga T
    Int J Oncol; 2016 Apr; 48(4):1477-84. PubMed ID: 26820693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
    Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y
    Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous inhibition of metastasis and growth of breast cancer by co-delivery of twist shRNA and paclitaxel using pluronic P85-PEI/TPGS complex nanoparticles.
    Shen J; Sun H; Xu P; Yin Q; Zhang Z; Wang S; Yu H; Li Y
    Biomaterials; 2013 Feb; 34(5):1581-90. PubMed ID: 23146437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine induction of invasive and metastatic phenotypes by the MIF-CXCR4 axis in drug-resistant human colon cancer cells.
    Dessein AF; Stechly L; Jonckheere N; Dumont P; Monté D; Leteurtre E; Truant S; Pruvot FR; Figeac M; Hebbar M; Lecellier CH; Lesuffleur T; Dessein R; Grard G; Dejonghe MJ; de Launoit Y; Furuichi Y; Prévost G; Porchet N; Gespach C; Huet G
    Cancer Res; 2010 Jun; 70(11):4644-54. PubMed ID: 20460542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schiff base-Poloxamer P85 combination demonstrates chemotherapeutic effect on prostate cancer cells in vitro.
    Demirci S; Doğan A; Türkmen NB; Telci D; Rizvanov AA; Şahin F
    Biomed Pharmacother; 2017 Feb; 86():492-501. PubMed ID: 28012929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.